Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancerKAIRA, Kyoichi; NAITO, Tateaki; TSUYA, Asuka et al.Lung cancer. 2010, Vol 68, Num 1, pp 99-104, issn 0169-5002, 6 p.Article

Evaluation of gefitinib efficacy according to body surface area in patients with non-small cell lung cancer harboring an EGFR mutationIGAWA, Satoshi; KASAJIMA, Masashi; KATONO, Ken et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 5, pp 939-946, issn 0344-5704, 8 p.Article

Gefitinib Plus Paclitaxel after Failure of Gefitinib in Non-small Cell Lung Cancer Initially Responding to GefitinibSHUKUYA, Takehito; TAKAHASHI, Toshiaki; ENDO, Masahiro et al.Anticancer research. 2009, Vol 29, Num 7, pp 2747-2751, issn 0250-7005, 5 p.Article

Utility of ¹⁸FDG-PET for differentiating the grade of malignancy in thymic epithelial tumorsENDO, Masahiro; NAKAGAWA, Kazuo; YAMAMOTO, Nobuyuki et al.Lung cancer. 2008, Vol 61, Num 3, pp 350-355, issn 0169-5002, 6 p.Article

Efficacy of Amrubicin for Non-small Cell Lung Cancer after Failure of Two or More Prior Chemotherapy RegimensIGAWA, Satoshi; TAKAHASHI, Toshiaki; NAKAMURA, Yukiko et al.Anticancer research. 2008, Vol 28, Num 6B, pp 3855-3858, issn 0250-7005, 4 p.Article

Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancerASAKUMA, Maiko; YAMAMOTO, Michiko; IGAWA, Satoshi et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 6, pp 1529-1536, issn 0344-5704, 8 p.Article

Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinomaIGAWA, Satoshi; MURAKAMI, Haruyasu; ENDO, Masahiro et al.Lung cancer. 2010, Vol 67, Num 2, pp 194-197, issn 0169-5002, 4 p.Article

Evaluation of Amrubicin as a Third or Later Line of Chemotherapy for Advanced Non-Small Cell Lung CancerIGAWA, Satoshi; SASAKI, Jiichiro; ISHIHARA, Mikiko et al.Chemotherapy (Basel). 2013, Vol 59, Num 2, pp 99-105, issn 0009-3157, 7 p.Article

Comparison of chemotherapy for unresectable pulmonary high-grade non-small cell neuroendocrine carcinoma and small-cell lung cancerIGAWA, Satoshi; WATANABE, Reiko; YAMAMOTO, Nobuyuki et al.Lung cancer. 2010, Vol 68, Num 3, pp 438-445, issn 0169-5002, 8 p.Article

Successful rechallenge with erlotinib in a patient with EGFR-mutant lung adenocarcinoma who developed gefitinib-related interstitial lung diseaseFUKUI, Tomoya; OTANI, Sakiko; HATAISHI, Ryuji et al.Cancer chemotherapy and pharmacology. 2010, Vol 65, Num 4, pp 803-806, issn 0344-5704, 4 p.Article

Impacts of Treatment Lines and Initiation Timing of Erlotinib for Advanced Non-small Cell Lung CancerAOKI, Takuya; IGAWA, Satoshi; MASUDA, Noriyuki et al.Anticancer research. 2012, Vol 32, Num 2, pp 601-608, issn 0250-7005, 8 p.Article

PHASE I RESULTS OF VINORELBINE WITH CONCURRENT RADIOTHERAPY IN ELDERLY PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER: WEST JAPAN THORACIC ONCOLOGY GROUP (WJTOG3005-DI)HARADA, Hideyuki; SETO, Takashi; YAMAMOTO, Nobuyuki et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 5, pp 1777-1782, issn 0360-3016, 6 p.Article

Nitric oxide generated by iNOS reduces deformability of Lewis lung carcinoma cellsIGAWA, Satoshi; HAYASHI, Izumi; TANAKA, Naohiko et al.Cancer science. 2004, Vol 95, Num 4, pp 342-347, issn 1347-9032, 6 p.Article